BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36407163)

  • 1. Toxic Epidermal Necrolysis: A Case Report on a Drug-Induced Phenomenon.
    Pamnani S; Bakshi SS; Acharya S
    Cureus; 2022 Oct; 14(10):e30407. PubMed ID: 36407163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbamzepine-induced toxic epidermal necrolysis.
    Chowta NK; Chowta MN; Ramapuram J; Kumar P; Fazil A
    Indian J Crit Care Med; 2011 Apr; 15(2):123-5. PubMed ID: 21814379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of clinical features of oxcarbazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Yan Q; Liu X; Lei H; Liu R; Hu Y
    Front Med (Lausanne); 2023; 10():1232969. PubMed ID: 37881633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbamazepine induced toxic epidermal necrolysis and Stevens-Johnson syndrome overlapping during pregnancy in a South-East Asian patient: A case report.
    Shrestha O; Pant P; Devkota N; Gurung D; Shrestha DB
    Ann Med Surg (Lond); 2021 Aug; 68():102616. PubMed ID: 34386220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hasegawa A; Abe R
    F1000Res; 2020; 9():. PubMed ID: 32595945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review.
    Arora R; Pande RK; Panwar S; Gupta V
    Indian J Crit Care Med; 2021 May; 25(5):575-579. PubMed ID: 34177178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
    Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
    Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug-induced toxic epidermal necrolysis with secondary aspergillus fumigatus infection: a case report].
    Zhang S; Liu XY; Zhang JZ; Cai L; Zhou C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):977-980. PubMed ID: 31624410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stevens-Johnson Syndrom and Toxic Epidermal Necrolysis--based on literature].
    Łoboda J; Dudzik A; Chomyszyn-Gajewska M
    Przegl Lek; 2015; 72(1):35-7. PubMed ID: 26076576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome progressing to toxic epidermal necrolysis with haloperidol and carbamazepine combination.
    Kumar A; Sarkar S; Praharaj SK; Akhtar S; Diwakar M
    Ind Psychiatry J; 2011 Jul; 20(2):131-3. PubMed ID: 23271869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use.
    Suresh Kumar PN; Thomas B; Kumar K; Kumar S
    Indian J Psychiatry; 2005 Apr; 47(2):121-3. PubMed ID: 20711297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
    Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
    Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW; Shih KC; Chan JCY; Lai JSM; Ng ALK
    BMC Ophthalmol; 2017 May; 17(1):65. PubMed ID: 28499410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can vitamin B-complex aggravate the carbamazepine induced toxic epidermal necrolysis?
    Fegade MV; Bhounsule SA; Pereira I
    J Clin Diagn Res; 2012 Nov; 6(9):1571-3. PubMed ID: 23285463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.